BEKHealth has filed a notice of an exempt offering of securities to raise $7,395,353.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, BEKHealth is raising $7,395,353.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Jason Baumgartner played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About BEKHealth
BEKHealth has developed the industry’s most advanced system for ingesting EMR data, conducting trial feasibility, and identifying protocol eligible patients for clinical trials. With the ability to cover >95% of a trial protocol, the BEKHealth solution guarantees unprecedented accuracy and operational improvement. Designed by researchers, for researchers: The only platform offering EMR Data Integration, Clinical Research Workflow, and Performance Analytics. Founded in 2017, BEKHealth is a private company owned by its founder and a small group of external advisors.
To learn more about BEKHealth, visit http://www.bekhealth.com/
Contact:
Jason Baumgartner, President and Chief Executive Officer
551-265-8778
https://www.linkedin.com/in/jason-baumgartner-113591/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.